Appeal court paves way for launch of Sandoz’ Reletrans

by | Aug 5, 2016 | | 0

Novartis’ generics arm Sandoz is launching its long-acting buprenophine patch Reletrans in the UK following victory in a patent battle with Napp Pharmaceuticals.

Read More